Opinion statement
Heart failure is a highly prevalent disorder, with significant economic impact, and is associated with excess morbidity and mortality. One factor that may contribute to the progressively declining course of heart failure is the occurrence of recurrent episodes of apnea and hypopnea. There are two major kinds of sleep-related breathing disorders: obstructive and central sleep apnea. In patients with heart failure, in contrast to the general population, central sleep apnea is the most common form of sleep-related breathing disorder. Episodes of apnea, hypopnea, and the subsequent hyperpnea cause sleep disruption, arousals, hypoxemia-reoxygenation, hypercapnia/hypocapnia, and changes in intrathoracic pressure. These pathophysiologic consequences of sleep-related breathing disorders have deleterious effects on the cardiovascular system, and may be even more pronounced in the setting of established heart failure and coronary artery disease. Therefore, sleep apnea in heart failure should be treated. Central sleep apnea may be treated with nocturnal supplemental nasal oxygen, theophylline, or nasal-positive pressure devices, such as nasal continuous positive airway pressure (CPAP). The treatment of choice for obstructive sleep apnea is nasal CPAP. Although long-term controlled trials of the effect of treatment of sleep apnea on mortality in patients with heart failure are still pending, treatment of sleep apnea, both obstructive and central, does result in a decrease in sympathetic activity and an improvement in systolic function, which are known surrogates of mortality. Therefore, diagnosis and treatment of sleep-related breathing disorders may increase survival of patients with heart failure.
Similar content being viewed by others
References and Recommended Reading
Javaheri S: Sleep-related breathing disorders in heart failure. In Heart Failure, A Companion to Braunwald’s Heart Disease. Edited by Mann DL. Philadelphia: WB Saunders; 2004:471–487. Reviews cardiovascular consequences of sleep apnea in heart failure.
Javaheri S: Heart failure. In Principles and Practice of Sleep Medicine, edn 4. Edited by Kryger MH, et al. Philadelphia: WB Saunders; 2005:1208–1217. The most updated article regarding sleep-related breathing disorders in heart failure.
Javaheri S, ParkerTJ, Wexler L, et al.: Occult sleep-disordered breathing in stable congestive heart failure. Ann Intern Med 1995, 122:487–492. [Published erratum appears in Ann Intern Med 1995, 123:77.]
Javaheri S, Parker TJ, Liming JD, et al.: Sleep apnea in 81 ambulatory male patients with stable heart failure: types and their prevalences, consequences, and presentations. Circulation 1998, 97:2154–2159.
Somers VK, Dyken ME, Mark AL, et al.: Sympatheticnerve activity during sleep in normal subjects. N Engl J Med 1993, 328:303–307.
Fletcher EC, Proctor M, Yu J, et al.: Pulmonary edema develops after recurrent obstructive apneas. Am J Respir Crit Care Med 1999, 160:1688–1696.
Hanly PJ, Millar TW, Steljes DG, et al.: Respiration and abnormal sleep in patients with congestive heart failure. Chest 1989, 96:480–488.
Lofaso F, Verschueren P, Rande JLD, et al.: Prevalence of sleep-disordered breathing in patients on a heart transplant waiting list. Chest 1994, 106:1689–1694.
Sin DD, Fitzgerald F, Parker JD, et al.: Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999, 160:1101–1106.
Solin P, Bergin P, Richardson M, et al.: Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 1999, 99:1574–1579.
Tremel F, Pépin JL, Veale D, et al.: High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J 1999, 20:1201–1209.
Fries R, Bauer D, Heisel A, et al.: Clinical significance of sleep-related breathing disorders in patients with implantable cardioverter deflbrillators. Pace 1999, 22:223–227.
Lanfranchi PA, Braghiroli A Bosimini E, et al.: Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999, 99:1435–1440.
Javaheri S: Central sleep apnea in congestive heart failure: prevalence, mechanisms, impact, and therapeutic options. Semin Respir Crit Care Med 2005, 26:44–55.
Young T, Palta M, Dempsey J, et al.: The occurrence of sleep disordered breathing among middle aged adults. N Engl J Med 1993, 328:1230–1235.
Chan J, Sanderson J, Chan W, et al.: Prevalence of sleep-disordered breathing in diastolic heart failure. Chest 1997, 111:1488–1493.
Young T, Peppard PE, Gottlieb DJ: Epidemiology of obstructive sleep apnea. Am J Respir Crit Care Med 2002, 165:1217–1239.
Mooe T, Franklin KA, Holmstrom K, et al.: Sleep-disordered breathing and coronary artery disease: longterm prognosis. Am J Respir Crit Care Med 2001, 164:1910–1913.
Peker Y, Hedner J, Kraiczi H, et al.: Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000, 162:81–86. Showed that obstructive sleep apnea increases the mortality in patients with established coronary artery disease.
Findley LJ, Zwillich CW, Ancoli-Israel S, et al.: Cheyne-Stokes breathing during sleep in patients with left ventricular heart failure. South Med J 1985, 78:11–15.
Hanly P, Zuberi-Khkhar N: Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 1996, 153:272–276.
Ancoli-Israel S, DuHamel ER, Stepnowsky C, et al.: The relationship between congestive heart failure, sleep apnea and mortality in older men. Chest 2003, 124:1400–1405.
Sin DD, Logan AG, Fitzgerald FS, et al.: Effects of continuous positive airway pressure on cardiovascular out-comes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000, 102:61–66. This report of a small number of patients with systolic heart failure showed that patients with central sleep apnea have a higher mortality than patients without central sleep apnea, and treatment of central sleep apnea with the CPAP device improves survival.
Leite JJ, Mansur AJ, de Freitas HFG, et al.: Periodic breathing during incremental exercise predicts mortality in patients with chronic heart failure evaluated for cardiac transplantation. J Am Coll Cardiol 2003, 41:2175–2181.
Andreas S, Hagenah G, Möller C, et al.: Cheyne-Stokes respiration and prognosis in congestive heart failure. Am] Cardiol 1996, 78:1260–1264.
Roebuck T, Solin P, Kaye DM et al.: Increased long term mortality in heart failure due to sleep apnea is not yet proven. European Respir J 2004, 23:735–740.
Javaheri S: Prevalence and prognostic significance of sleep apnea in heart failure. In Sleep Apnea. Implications in Cardiovascular and Cerebrovascular Disease. Edited by Bradley TD, Floras JS. New York, NY: Marcel Dekker; 2000:415–433.
Kaneko Y, Floras JS, Usui K, et al.: Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003, 248:1233–1241. This is a small study of 24 patients with systolic heart failure and obstructive sleep apnea randomized to a control group versus CPAP therapy. It showed that the use of this device improves left ventricular ejection fraction.
MansfieldDR, Gollogly C, Kaye DM: Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004, 169:361–366. This study of a large number of patients with obstructive sleep apnea confirmed the results of Kaneko et al. [28].
Javaheri S: Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 2000, 101:392–397. Showed that use of CPAP device in patients with systolic heart failure and central sleep apnea decreases the number of nocturnal ventricular arrhythmias when central sleep apnea improves with use of the device.
Naughton MT, Bernard DC, Liu PR et al.: Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1995, 152:473–479.
Staniforth AD, Kinneart WJM, Hetmanski DJ, et al.: Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J 1998, 19:922–928.
Andreas S, Bingeli C, Mohacsi P, et al.: Nasal oxygen and muscle sympathetic nerve activity in heart failure. Chest 2003, 123:366–371. This study confirms the results of Staniforth et al. [32] using peroneal nerve sympathetic activity.
Andreas S, Clemens C, Sandholzer H, et al.: Improvement of exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol 1996, 27:1486–1490.
Hudgel D, Chapman KR, Franks C, et al.: Changes in inspiratory muscle electrical activity and upper airway resistance during periodic breathing induced by hypoxemia during sleep. Am Rev Respir Dis 1987, 135:899–906.
Shepard JW, Pevernagie DA, Stanson AW, et al.: Effects of changes in central venous pressure on upper airway size in patients with obstructive sleep apnea. Am J Respir Crit Care Med 1996, 153:250–254.
Calle EE, Thun MJ, Petrelli JM, et al.: Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999, 341:1097–1105.
Kenchaiah S, Evans JC, Levy D, et al.: Obesity and the risk of heart failure. N Engl J Med 2002, 347:305–313.
JavaheriS: Pembrey’s Dream: the time has come for a long-term trial of nocturnal supplemental nasal oxygen to treat central sleep apnea in congestive heart failure. Chest 2003, 123:322–325. This editorial emphasized the need for long-term doubleblind, placebo-controlled studies to determine if use of nocturnal oxygen improves mortality of patients with systolic heart failure and central sleep apnea.
Dowdell WT, Javaheri S, McGinnis W: Cheyne-Stokes respiration presenting as sleep apnea syndrome. Clinical and polysomnographic features. Am Rev Respir Dis 1990, 141:871–879.
Arendt J, Bojkowski C, Franey C, et al.: Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol. J Clin Endocrinol Metab 1985, 60:1166–1173.
Stoschitzky K, Sakotnik A, Lercher P, et al.: Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol 1999, 55:111–115.
Javaheri S, Abraham W, Brown C, et al.: Prevalence of obstructive sleep apnea and periodic limb movement in 45 subjects with heart transplantation. Eur Heart J 2004, 25:260–266. This is the largest and most systematic study showing occurrence of obstructive sleep apnea and periodic limb movement in cardiac transplant recipients.
Javaheri S: Heart failure and sleep apnea: emphasis on practical therapeutic options. Clin Chest Med 2003, 24:207–222. A review article regarding use of positive pressure airway devices in patients with heart failure and various types of sleep apnea.
Keily JL, Deegan P, Buckley A, et al.: Efficacy of nasal continuous positive airway pressure therapy in chronic heart failure: importance of underlying cardiac rhythm. Thorax 1998, 53:956–962.
Guilleminault C, Clerk A Labanowski M, et al.: Cardiac failure and benzodiazepines. Sleep 1993, 16:524–528.
Davies RJO, Harrington KJ, Ormerod JM, et al.: Nasal continuous positive airway pressure in chronic heart failure with sleep-disordered breathing. Am Rev Respir Dis 1993, 147:630–634.
Buckle P, Millar T, Kryger M: The effects of short-term nasal CPAP on Cheyne-Stokes respiration in congestive heart failure. Chest 1992, 102:31–35.
Teschler H, Döhring J, Wang YM, Berthon-Jones M: Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 2001, 64:614–619.
Garrigue S, Bordier P, Jais P, et al.: Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med 2002, 346:404–412.
Abraham WT, Hayes DL: Cardiac resynchronization therapy for heart failure. Circulation 2004, 108:2596–2603.
Javaheri S, Parker TJ, Wexler L, et al.: Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 1996, 335:562–567.
Hanly PF, Millar TW, Steljes DG, et al.: The effect of oxygen on respiration and sleep in patients with congestive heart failure. Ann Intern Med 1989, 111:777–782.
Javaheri S, Ahmed M, Parker TJ, Brown CR: Effects of nasal O2 on sleep-related disordered breathing in ambulatory patients with stable heart failure. Sleep 1999, 22:1101–1106.
Javaheri S, Teppama LJ, Evers JAM: Effects of aminophylline on hypoxemia-induced ventilatory depression in cats. J Appl Physiol 1988, 64:1837–1843.
Javaheri S, Evers JAM, Teppema LJ: Increase in ventilation caused by aminophylline in the absence of changes in ventral extracellular fluid pH and PCO2. Thorax 1989, 44:121–125.
Javaheri S, Guerra LF: Lung function, hypoxic and hypercapnic ventilatory responses, and respiratory muscle strength in normal subjects taking oral theophylline. Thorax 1990, 45:743–747.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Javaheri, S., Wexler, L. Prevalence and treatment of breathing disorders during sleep in patients with heart failure. Curr Treat Options Cardio Med 7, 295–306 (2005). https://doi.org/10.1007/s11936-005-0040-0
Issue Date:
DOI: https://doi.org/10.1007/s11936-005-0040-0